Ten Bio News
Spring Conference Season
As the Northern Hemisphere welcomes Spring 2023 the new season of industry conferences and symposia kicks off. And after the return to face to face
Your Skin Research Partner – Ten Bio
service /ˈsəːvɪs/ Noun: ‘the action of helping or doing work for someone’ A note from the Chair Ten Bio’s early experience with our anchor clients has
Ten Bio named finalist in Scotland’s Life Science award.
Ten Bio is proud to announce that our company has been named one of three finalists in Scotland’s Life Science award in the category ‘Innovation
The origins of TenSkin™
Entering our third year since spin out, it’s time to celebrate the origins of our technology which has brought Ten Bio early success in a
‘When I was two, I was nearly new’ ….
‘When I was two I was nearly new’ … with thanks to A. A. Milne for the line from his 1927 poem ‘Now we are
Our differentiation in wound management….
In the previous note from the chairman I emphasized the potential role for Ten Bio in the area of wound management. My reason for that
Dr Paul Campbell seconded to Ten Bio through UK Medical Research Council Innovation Scholarship
Dr Paul Campbell, Reader in Physics at the University of Dundee has recently begun a secondment to Ten Bio through an Innovation Scholarship funded by the UK’s Medical Research Council.
Proud to be presenting at the Society for Investigative Dermatology Annual Meeting in Portland
May 18-21, 2022 We are proud to be exhibiting and presenting at the Society for Investigative Dermatology annual meeting later this week. Our Founder and
It’s just the start of Ten Bio’s journey…
A note from the Chair. I was introduced to Ten Bio’s founders in November 2019. I was immediately engaged by two things: firstly, the logic
Predicting human response to gene-based therapies in preclinical evaluation
Why do so many gene therapies fail in clinical trials? A closer look at the preclinical gap—and how TenSkin™ is helping close it.
Beyond animal models: The future of skin testing is human-relevant and ready
As regulatory momentum builds and new human-relevant technologies emerge, the conversation is shifting. The question is no longer if we can replace animal testing in skin research — but how fast. This article explores why models like TenSkin™ offer a scalable, scientifically robust alternative that’s already reshaping preclinical research.
Setting the standard: How TenSkin is shaping regulatory change in skin testing
As regulators move away from animal testing, clear validation frameworks are needed to support alternatives. Explant models like TenSkin™ offer a human-relevant solution for preclinical skin research, improving predictability and reproducibility.
Pollution protection
Urban pollution drives demand for advanced skincare. Ten Bio’s TenSkin™ offers a next generation ex vivo model to test anti-pollution products, providing crucial insights that accelerate the development of scientifically validated, high-impact solutions.
Happy Holidays 2024
Spreading Holiday cheer – from the Ten Bio team to all of our clients, collaborators and partners – past, present and future! As the year winds down, we want to take a moment to express a heartfelt thank you for being a part of our journey through 2024.
The advantages of extended viability in TenSkin™ for dermatological research
Ten Bio’s TenSkin™ ex vivo human skin model offers two-week viability, enhancing the depth and reliability of skin studies, allowing for more detailed insights into skin health and treatment efficacy.